Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours

por Tawbi, H A, Villaruz, L, Tarhini, A, Moschos, S, Sulecki, M, Viverette, F, Shipe-Spotloe, J, Radkowski, R, Kirkwood, J M
Publicado 2011

Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial...

por Argiris, A, Lee, J W, Stevenson, J, Sulecki, M G, Hugec, V, Choong, N W, Saltzman, J N, Song, W, Hansen, R M, Evans, T L, Ramalingam, S S, Schiller, J H
Publicado en Ann Oncol (2017)